PGLDF yields 413.22% · JNJ yields 2.14%● Live data
📍 PGLDF pulled ahead of the other in Year 1
Combined, PGLDF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PGLDF + JNJ for your $10,000?
P2 Gold Inc., a junior mining company, engages in the acquisition, exploration, and development of mineral properties in Canada and the United States. It primarily explores for gold, copper, silver, lead, and zinc deposits. The company holds an interest in the Gabbs project comprising 421 unpatented lode mining claims and one patented lode mining claim covering 3,300 hectares in Nevada; the Silver Reef project covering an area of approximately 23,000 hectares; and the BAM property, which includes ten mineral tenures that covers an area of approximately 8,100 hectares. It also holds an interest in the Lost Cabin property comprising 106 unpatented lode mining claims covering an area of approximately 2,190 acres, located in Lake County, Oregon. The company was formerly known as Central Timmins Exploration Corp. and changed its name to P2 Gold Inc. in August 2020. P2 Gold Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Full PGLDF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.